WebFeb 6, 2024 · Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The … WebApr 12, 2024 · Recent reports have lowered Editas Medicine’s price target from $36.00 to $30.00 and raised it from $13.00 to $15.00. Editas Medicine’s stock opened at $6.71 and has a 50-day moving average of $8.70 and a 200-day moving average of $9.86. The company’s market capitalization is $462.79 million, and it has a PE ratio of -2.09 and a …
GE’s stock gains after UBS boosts price target by 15%
WebEditas Medicine stock price target cut to $35 from $80 at Truist Nov. 18, 2024 at 7:08 a.m. ET by Tomi Kilgore Editas Medicine started at neutral with $18 stock price target at BofA... WebEditas Medicine, Inc. (EDIT) Stock Price, News, Quote & History - Yahoo Finance My Portfolio Personal Finance Industries U.S. markets closed S&P Futures 0.00(0.00%) … my mother gave justin the advertisement
Goldman Sachs Just Put Editas Stock on Sale — Buy the Dip
WebFind real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business. EDIT - Editas Medicine Inc Stock quote - … WebApr 5, 2024 · The average twelve-month price prediction for Editas Medicine is $15.33 with a high price target of $35.00 and a low price target of $7.00. Do Wall Street analysts like Editas Medicine more than its competitors? Analysts like Editas Medicine less than … WebApr 11, 2024 · The mean of analysts' price targets for Editas (EDIT) points to a 72.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts ... 2 months ago - Zacks Investment Research Editas (EDIT) Moves Ahead With its Portfolio Reprioritization my mother frank